Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
Health
Rebecca Thomas

Brexit denies UK children access to life-extending drug for aggressive brain cancer

UK children with a rare and aggressive brain cancer have been locked out of a potentially life-extending drug trial due to Brexit.

Around 30 children in Britain each year are diagnosed with Diffuse Intrinsic Pontine Glioma (DIPG) – an incurable and inoperable tumour that affects the brainstem, which controls vital functions such as breathing, swallowing, and facial expressions.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.